ema glp-1 vision loss recommendation 2025 Medications and NAION: What Patients Should Know About Sudden EMA expands probe of possible

Safety Considerations When Combining Metformin with GLP-1 Therapy The primary safety consideration involves gastrointestinal side effects, which occur more frequently when GLP-1 medications are introduced, particularly nausea and constipation during dose escalation phases

GLP-1 also reduces levels of glucagon, a hormone that typically raises blood sugar, further stabilizing your bodys blood glucose response

Both medications are given as a once-weekly subcutaneous injection and share similar pharmacokinetic characteristics, such as absorption, distribution, metabolism, and excretion

This kind of information allows you to adjust your plan thoughtfully

00:02:13 Narrator Youll also hear practical advice from panelists on TRCs editorial advisory board, Dr